Targeting DNA-Dependent Protein Kinase for Cancer Therapy.

about

Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies.

P2860

Q55710290-E3332209-57E8-4435-BBEC-2E8397D25BD6

P2860

Targeting DNA-Dependent Protein Kinase for Cancer Therapy.

Item

http://www.wikidata.org/entity/Q39250742

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Targeting DNA-Dependent Protein Kinase for Cancer Therapy.

@en

Targeting DNA-Dependent Protein Kinase for Cancer Therapy.

@nl

type

Item

label

Targeting DNA-Dependent Protein Kinase for Cancer Therapy.

@en

Targeting DNA-Dependent Protein Kinase for Cancer Therapy.

@nl

prefLabel

Targeting DNA-Dependent Protein Kinase for Cancer Therapy.

@en

Targeting DNA-Dependent Protein Kinase for Cancer Therapy.

@nl

P1476

Targeting DNA-Dependent Protein Kinase for Cancer Therapy

@en

P2093

Alfie Brennan

http://www.w3.org/2001/XMLSchema#string

Céline Cano

http://www.w3.org/2001/XMLSchema#string

Suzannah J Harnor

http://www.w3.org/2001/XMLSchema#string

P2860

The DNA-damage response in human biology and disease

Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine

DNA double-strand breaks: signaling, repair and the cancer connection

Molecular views of recombination proteins and their control

A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia

ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers

The DNA-dependent protein kinase

Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction

2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK).

Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries.

P304

895-900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201700143

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alfie Brennan

Celine Cano

Suzannah J Harnor

P577

2017-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28423228

http://www.w3.org/2001/XMLSchema#string

Targeting DNA-Dependent Protein Kinase for Cancer Therapy.

about

P2860

P2860

Targeting DNA-Dependent Protein Kinase for Cancer Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698